In this episode of Medical News Update, we explore innovative advancements in blood glucose regulation, focusing on smart insulin and dual-hormone therapy. Researchers at Indiana University School of Medicine have developed a fusion protein that combines insulin and glucagon, offering potential stability and effectiveness in managing blood sugar levels. Early animal studies show promise, but more research is needed before human clinical trials. Join us to learn how this could revolutionise type 1 diabetes care and make treatment more accessible globally.

 #DiabetesCare #InnovativeMedicine

In today's episode, we discuss an important alert from the WHO regarding semaglutide medicines like Ozempic, Rybelsus, and Wegovy, which are used for type 2 diabetes and weight management. A rare but serious side effect called non-arteritic anterior ischemic optic neuropathy (NAY-on), leading to sudden vision loss, has been linked to these drugs. We review what the European Medicines Agency has found, the risks involved, and what patients should do if they experience vision changes. Awareness and prompt action are crucial. Learn more about how to manage these risks while benefiting from these medications.

00:00 Introduction to Today's Episode

00:01 Understanding Semaglutide Medicines

00:17 Serious Side Effect Alert: NAY-on

00:49 Risk Assessment and Recommendations

01:45 Guidance for Patients on Semaglutide

02:19 Conclusion

Can diet sodas and sugar-free foods speed up brain ageing? A new study from the ELSA-Brasil cohort, published in Neurology, finds that artificial sweeteners are linked to faster memory and cognitive decline, especially in midlife adults and those with diabetes. In this episode, we break down the study, its strengths and limitations, and what it means for everyday dietary choices.